Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LSD acutely impairs working memory, executive functions, and cognitive flexibility, but not risk-based decision-making
Thomas Pokorny, Patricia Duerler, Erich Seifritz, et al.
Psychological Medicine (2019) Vol. 50, Iss. 13, pp. 2255-2264
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder
Manoj K. Doss, Michal Považan, Monica D. Rosenberg, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 236
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 202-277
Open Access | Times Cited: 163
Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention
Frederick S. Barrett, Samuel R. Krimmel, Roland R. Griffiths, et al.
NeuroImage (2020) Vol. 218, pp. 116980-116980
Open Access | Times Cited: 149
Models of psychedelic drug action: modulation of cortical-subcortical circuits
Manoj K. Doss, Maxwell B. Madden, Andrew Gaddis, et al.
Brain (2021) Vol. 145, Iss. 2, pp. 441-456
Open Access | Times Cited: 144
Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review
Michiel van Elk, David B. Yaden
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104793-104793
Open Access | Times Cited: 113
Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex
Manesh Girn, Leor Roseman, Boris C. Bernhardt, et al.
NeuroImage (2022) Vol. 256, pp. 119220-119220
Open Access | Times Cited: 75
Supportive Touch in Psychedelic Assisted Therapy
Logan Neitzke‐Spruill, Caroline Beit, Lynnette A. Averill, et al.
The American Journal of Bioethics (2025) Vol. 25, Iss. 1, pp. 29-39
Closed Access | Times Cited: 5
Spontaneous and deliberate creative cognition during and after psilocybin exposure
Natasha L. Mason, Kim P. C. Kuypers, Johannes T. Reckweg, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 99
Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review
Kristin Heuschkel, Kim P. C. Kuypers
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 74
The acute effects of classic psychedelics on memory in humans
C. J. Healy
Psychopharmacology (2021) Vol. 238, Iss. 3, pp. 639-653
Closed Access | Times Cited: 73
Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?
Rita Kočárová, Jiřı́ Horáček, Robin Carhart‐Harris
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 68
Acute psilocybin enhances cognitive flexibility in rats
Alejandro Torrado Pacheco, Randall J. Olson, Gabriela Garza, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 7, pp. 1011-1020
Open Access | Times Cited: 41
Psychedelic therapy in the treatment of addiction: the past, present and future
Rayyan Zafar, Maxim Siegel, Rebecca Harding, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 38
Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry
Gregory Barber, Charles C. Dike
Psychiatric Services (2023) Vol. 74, Iss. 8, pp. 838-846
Closed Access | Times Cited: 37
The costs and benefits of psychedelics on cognition and mood
Ceyda Sayalı, Frederick S. Barrett
Neuron (2023) Vol. 111, Iss. 5, pp. 614-630
Open Access | Times Cited: 26
Potential Differences in Psychedelic Actions Based on Biological Sex
Sheida Shadani, Kyna‐Anne Conn, Zane B. Andrews, et al.
Endocrinology (2024) Vol. 165, Iss. 8
Open Access | Times Cited: 9
The intensity of the psychedelic experience is reliably associated with clinical improvements: a systematic review and meta-analysis
Bruno Roméo, E. Kervadec, Baptiste Fauvel, et al.
Neuroscience & Biobehavioral Reviews (2025) Vol. 172, pp. 106086-106086
Closed Access | Times Cited: 1
The therapeutic potential of microdosing psychedelics in depression
Kim P. C. Kuypers
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 60
Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective
John R. Kelly, Claire M. Gillan, Jack Prenderville, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 51
On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review
Richard J. Zeifman, Nikhita Singhal, Leah Breslow, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 436-451
Open Access | Times Cited: 47
LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility
Isabel Wießner, Rodolfo Olivieri, Marcelo Falchi, et al.
European Neuropsychopharmacology (2022) Vol. 58, pp. 7-19
Closed Access | Times Cited: 32
Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans
Jonathan W. Kanen, Qiang Luo, Mojtaba Rostami Kandroodi, et al.
Psychological Medicine (2022) Vol. 53, Iss. 14, pp. 6434-6445
Open Access | Times Cited: 32
A neurobiological perspective on social influence: Serotonin and social adaptation
Patricia Duerler, Franz X. Vollenweider, Katrin H. Preller
Journal of Neurochemistry (2022) Vol. 162, Iss. 1, pp. 60-79
Open Access | Times Cited: 29
Prevalence and therapeutic impact of adverse life event reexperiencing under ceremonial ayahuasca
Brandon Weiss, Aleksandra Wingert, David Erritzøe, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Nootropic effects of LSD: Behavioral, molecular and computational evidence
Isis M. Ornelas, Felipe A. Cini, Isabel Wießner, et al.
Experimental Neurology (2022) Vol. 356, pp. 114148-114148
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top